Expedition Therapeutics

San Francisco, CA · Founded 2024 · Privately Held (backing)

Operator of biopharmaceutical development services intended for translational research and global licensing purposes. Expedition Therapeutics is based in San Francisco, CA and was founded in 2024. It was valued at $1 billion at its Series B in Aug 2026, the last priced event on record. It has raised $165 million across 1 recorded round; the latest was an $115 million Series B in Aug 2026.

PMV mark · valuation
$1.0B
Oct 2026
Priced at
its Series B
Aug 2026
Total raised
$165.0M
Last round
Series B
Aug 2026
What is Expedition Therapeutics worth?
$1.0BPrivateMarketView mark · Oct 2026

Valued at $1.0B at its Series B, Aug 2026. Nothing has traded since.

Free account
More of Expedition Therapeutics with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 14 names
  • ·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

1 priced round · 32 daily marks since · Aug 2026 – Oct 2026
▮▮
Series Brounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Expedition Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Aug 2026Series B$115.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Expedition Therapeutics valuation

Expedition Therapeutics was valued at $1 billion at its Series B in Aug 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

Recent activity

In the last 90 days, Expedition Therapeutics's record added 1 funding round.

How much has Expedition Therapeutics raised?

Expedition Therapeutics has raised $165 million in total; 1 of its rounds is on record. The largest on record was an $115 million Series B in Aug 2026. 1 of the rounds disclosed a post-money valuation.

How Expedition Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Expedition Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Expedition Therapeutics

What is Expedition Therapeutics worth?
Expedition Therapeutics is valued at $1.0B as of Oct 2026. Valued at $1.0B at its Series B, Aug 2026. Nothing has traded since.
How much has Expedition Therapeutics raised?
Expedition Therapeutics has raised $165.0M in total funding across 1 recorded rounds.
When did Expedition Therapeutics last raise?
Expedition Therapeutics last raised in Aug 2026 (Series B), raising $115.0M.